List of progestogens available in the United States

This is a complete list of progestogens (progesterone and progestins) and formulations that are approved by the FDA and available in the United States. Progestogens are used as hormonal contraceptives, in hormone replacement therapy for menopausal symptoms, and in the treatment of gynecological disorders.

For contraception

Combined contraceptives

Combined oral contraceptive pills

Discontinued:

Transdermal patches

Main article: Contraceptive patch

Vaginal rings

Combined injectable contraceptives

Discontinued:

Progestogen-only contraceptives

Progestogen-only pills

Main article: Progestogen-only pill

Discontinued:

Postcoital emergency contraceptive pills

Progestogen-only injectable contraceptives

Intrauterine devices

Discontinued:

Subdermal implants

For gynecological disorders, menopausal symptoms, and other conditions

Combined with estrogen

Oral pills

Discontinued:

Estradiol/progesterone (TX-001HR), a combination of estradiol and progesterone, is under development.[1]

Transdermal patches

Progestogen-only

Oral pills

Atypical:

Discontinued:

Oral suspensions

Vaginal gels

Vaginal inserts

Intramuscular injectables

Discontinued:

Miscellaneous

Progestogens not available in the United States

See also

Notes

  1. Pickar JH, Bon C, Amadio JM, Mirkin S, Bernick B (2015). "Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy". Menopause. 22 (12): 1308–16. doi:10.1097/GME.0000000000000467. PMC 4666011Freely accessible. PMID 25944519.
  2. Jame Abraham; James L. Gulley; Carmen J. Allegra (1 September 2009). Bethesda Handbook of Clinical Oncology. Lippincott Williams & Wilkins. pp. 612–. ISBN 978-0-7817-9558-6.
  3. Guido Eibl; Mouad Edderkaoui (22 April 2015). Risk Factors for Pancreatic Cancer: Underlying Mechanisms and Potential Targets. Frontiers Media SA. pp. 96–. ISBN 978-2-88919-468-1. In 1993, the Food and Drug Administration (FDA) approved megestrol acetate for the treatment of cancer anorexia-cachexia syndrome as well as cachexia due to chronic conditions, including human acquired immunodeficiency syndrome (AIDS).
  4. William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia. Elsevier. pp. 1411–. ISBN 978-0-8155-1856-3.
  5. Journal of the American Medical Women's Association. American Medical Women's Association. 1948. p. 354. Packaging: Pranone (anhydrohydroxy-progesterone) Tablets of 5, 10 or 25 mg., in boxes of 20, 40, 100 and 250 tablets.
  6. Revesz C, Chappel CI (1966). "Biological activity of medrogestone: a new orally active progestin". J. Reprod. Fertil. 12 (3): 473–87. PMID 4288903.

References


This article is issued from Wikipedia - version of the 11/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.